Michael Aviram

30.0k citations

387 papers · 24.3k indexed · 4 hit papers · h-index 85

Impact in

Biochemistry top 0.01%
- Antioxidant Activity and Oxidative Stress
- Phytochemicals and Antioxidant Activities
Clinical Biochemistry top 0.01%
- Paraoxonase enzyme and polymorphisms

Papers in

Clinical Biochemistry 123
- Paraoxonase enzyme and polymorphisms 115
Biochemistry 93
- Antioxidant Activity and Oxidative Stress 85

Co-authors: Mira Rosenblat Bianca Fuhrman Tony Hayek Nina Volkova Jacob Vaya Raymond Coleman J.G. Brook Marielle Kaplan
Journals: Atherosclerosis (56 papers)Biochemical and Biophysical Research Communications (22 papers)Arteriosclerosis Thrombosis and Vascular Biology (17 papers)BioFactors (13 papers)Free Radical Biology and Medicine (13 papers)
Partner nations: Israel United States Italy

In The Last Decade

Michael Aviram

385 papers receiving 23.1k citations

Hit Papers

align trajectories log scale

Comparison of Antioxidant Potency of Commonly Consumed Polyphenol-Rich Beverages in the United States 2008 · 543 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Journal of Agricultural and Food Chemistry
1999 Free Radical Biology and Medicine
1998 Journal of Clinical Investigation
1995 American Journal of Clinical Nutrition

Peers

Countries citing papers authored by Michael Aviram

Since Specialization

Citations

This map shows the geographic impact of Michael Aviram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Aviram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Aviram more than expected).

Fields of papers citing papers by Michael Aviram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Aviram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Aviram. The network helps show where Michael Aviram may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael Aviram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Aviram Line = papers co-authored together Michael Aviram links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of Pomegranate Extract Supplementation on Cardiovascular Risk Factors and Physical Function in Hemodialysis Patients Journal of Medicinal Food ·Fabrizio Alebardi, Peter J. Fitschen, Brandon M. Kistler, Jinhee Jeong, Shraddha Kumthekar, Michael Aviram, Shane A. Phillips, Bo Fernhall, Kenneth R. Wilund	2015	53
2	Monocyte-macrophage membrane possesses free radicals scavenging activity: stimulation by polyphenols or by paraoxonase 1 (PON1) Free Radical Research ·Mira Rosenblat, Mohammed Talea, Nina Volkova, Michael Aviram	2013	9
3	Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: Studies in vitro and in diabetic patients Nutrition ·Bianca Fuhrman, Nina Volkova, Michael Aviram	2009	66
4	Apolipoprotein E and its role in aging and survival Experimental Gerontology ·Francesca Bonomini, Francesca Filippini, Tony Hayek, Michael Aviram, Shlomo Keidar, Luigi Fabrizio Rodella, Raymond Coleman, Rita Rezzani	2009	48
5	Paraoxonase 1 Attenuates Human Plaque Atherogenicity: Relevance to the Enzyme Lactonase Activity Advances in experimental medicine and biology ·Mila. Auteur du texte Gray, Jacob Vaya, Michael Aviram	2009	22
6	Lipid Profile and Serum Characteristics of the Blind Subterranean Mole Rat, Spalax PLoS ONE ·Nicola J. Nasser, Marielle Kaplan, Eviatar Nevo, Michael Aviram	2009	4
7	Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 Journal of Lipid Research ·Mira Rosenblat, Raymond Coleman, Srinivasa T. Reddy, Michael Aviram	2008	50
8	Pomegranate Phenolics from the Peels, Arils, and Flowers Are Antiatherogenic: Studiesin Vivoin Atherosclerotic Apolipoprotein E-Deficient (E⁰) Mice andin Vitroin Cultured Macrophages and Lipoproteins Journal of Agricultural and Food Chemistry ·Michael Aviram, Nina Volkova, Raymond Coleman, Mark L. Dreher, Muntha K. Reddy, Daneel Ferreira, Mira Rosenblat	2008	214
9	A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity Biochemical and Biophysical Research Communications ·Maayan Shiner, Bianca Fuhrman, Michael Aviram	2006	32
10	Paraoxonase 1 (PON1) is present in postprandial chylomicrons Atherosclerosis ·Bianca Fuhrman, Nina Volkova, Michael Aviram	2005	53
11	Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine Atherosclerosis ·Mira Rosenblat, Jacob Vaya, Diana M. Shih, Michael Aviram	2004	167
12	Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages Free Radical Biology and Medicine ·Maayan Shiner, Bianca Fuhrman, Michael Aviram	2004	53
13	Dietary antioxidants stimulate the expression of paraoxonases which provide protection against atherosclerosis development Current Topics in Nutraceutical Research ·Michael Aviram	2003	5
14	Macrophage-released proteoglycans enhance LDL aggregation: studies in aorta from apolipoprotein E-deficient mice Atherosclerosis ·Irit Maor, Tony Hayek, Mark Hirsh, T. C. Iancu, Michael Aviram	2000	30
15	Macrophage Enrichment with the Isoflavan Glabridin Inhibits NADPH Oxidase-induced Cell-mediated Oxidation of Low Density Lipoprotein Journal of Biological Chemistry ·Mira Rosenblat, Paula A. Belinky, Jacob Vaya, Rachel Lévy, Tony Hayek, Raymond Coleman, Shoshana Merchav, Michael Aviram	1999	93
16	DIETARY SELENIUM INCREASES CELLULAR GLUTATHIONE PEROXIDASE ACTIVITY AND REDUCES THE ENHANCED SUSCEPTIBILITY TO LIPID PEROXIDATION OF PLASMA AND LOW-DENSITY LIPOPROTEIN IN KIDNEY TRANSPLANT RECIPIENTS Transplantation ·Osamah Hussein, Mira Rosenblat, Raffi Indejikian, Michael Aviram	1997	49
17	Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages. Gut ·Predrag Ljubuncic, Bianca Fuhrman, J. Oiknine, Michael Aviram, Arieh Bomzon	1996	100
18	Lesioned Low-Density Lipoprotein in Atherosclerotic Apolipoprotein E-Deficient Transgenic Mice and in Humans Is Oxidized and Aggregated Biochemical and Biophysical Research Communications ·Michael Aviram, Irit Maor, S Keidar, Tony Hayek, J. Oiknine, Jean-Jacques Hyest, Zvi Adler, I-Hui Chen, S Milo	1995	71
19	Preferential Inhibition of LDL Oxidation by the all-trans Isomer of β-Carotene in Comparison with 9-cis β-Carotene Clinical Chemistry and Laboratory Medicine (CCLM) ·Alexandra Lavy, Ami Ben Amotz, Michael Aviram	1993	50
20	The acute effects of high cholesterol and saturated fat diet on plasma lipoproteins and on platelet aggregation in normolipidemic subjects Nutrition reports international ·J.G. Brook, Eva Herzog, Michael Aviram	1986	3

About Michael Aviram

Michael Aviram is a scholar working on Clinical Biochemistry, Biochemistry, Nutrition and Dietetics, Endocrinology, Diabetes and Metabolism and Biochemistry, having authored 387 papers that have together received 24.3k indexed citations. Recurring topics across this work include Paraoxonase enzyme and polymorphisms (115 papers), Antioxidant Activity and Oxidative Stress (85 papers), Cynara cardunculus studies (80 papers), Lipoproteins and Cardiovascular Health (61 papers), Cholesterol and Lipid Metabolism (48 papers), Pomegranate: compositions and health benefits (46 papers), Atherosclerosis and Cardiovascular Diseases (45 papers) and Apelin-related biomedical research (40 papers). The work is most often cited by research in Biochemistry (6.0k citations), Clinical Biochemistry (6.5k citations), Nutrition and Dietetics (5.4k citations), Pharmacology (2.6k citations) and Biochemistry (2.1k citations). Michael Aviram has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Mira Rosenblat, Bianca Fuhrman, Tony Hayek, Nina Volkova, Jacob Vaya, Raymond Coleman, J.G. Brook, Marielle Kaplan, Roger S. Newton and Paula A. Belinky. Their work appears in journals such as Atherosclerosis, Biochemical and Biophysical Research Communications, Arteriosclerosis Thrombosis and Vascular Biology, BioFactors and Free Radical Biology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact